Breaking News Instant updates and real-time market news.

QRVO

Qorvo

$61.53

0.23 (0.38%)

08:38
05/22/19
05/22
08:38
05/22/19
08:38

Qorvo price target lowered to $75 from $85 at Craig-Hallum

Craig-Hallum analyst Anthony Stoss lowered his price target for Qorvo to $75 from $85 after the company lowered its June quarter guidance and provided September quarter guidance as well to account for the U.S. ban against Huawei. The analyst reiterates a Buy rating on the shares.

QRVO Qorvo
$61.53

0.23 (0.38%)

05/22/19
DADA
05/22/19
NO CHANGE
Target $66
DADA
Neutral
Qorvo price target lowered to $66 from $82 at DA Davidson
DA Davidson analyst Thomas Diffely lowered his price target on Qorvo to $66 and kept his Neutral rating while also lowering his FY20 and FY21 target EPS on the stock by $1 and $1.25 to $5.00 and $5.75 respectively. The analyst cites the company's announced stoppage of shipments to Huawei, which had accounted for about 15% of its overall revenue in FY19, in response to it being "blacklisted" by the Trump administration. Diffely adds that it is difficult to predict the duration of the ban, but believes that a conservative model of fully removing Huawei from his projections for Qorvo financials is warranted.
05/22/19
JPMS
05/22/19
NO CHANGE
Target $85
JPMS
Overweight
JPMorgan still sees 'meaningful upside' for Qorvo shares over midterm
JPMorgan analyst Bill Peterson lowered his price target for Qorvo to $85 from $90 but keeps an Overweight rating on the shares after the company cut its outlook to reflect the U.S. Department of Commerce ban of shipping components to Huawei. Despite the negative impact of the Huawei ban, Peterson continues to expect Qorvo to outperform over the next few years on "content gains" in mobile. Despite volatility in the market and the potential for additional headline risk, Qorvo's risk/reward profile remains favorable over the midterm, Peterson tells investors in a research note. He continues to expect "meaningful upside" for the shares.
05/21/19
OPCO
05/21/19
NO CHANGE
OPCO
Perform
Qorvo could be first to remove Huawei from estimates, says Oppenheimer
Oppenheimer analyst Rick Schafer notes that Qorvo lowered its Q1 outlook to reflect the recent U.S. Department of Commerce Huawei sales ban, which he believes comes as "little surprise" given the company's outsized Huawei exposure. Further, the analyst believes Qorvo could be the first of several semiconductor names to remove Huawei from estimates/de-risk. Schafer expects Huawei business likely comes back at some point, but "timing is uncertain." Given the challenged handset environment, he reiterates a Perform rating on the shares.
05/21/19
ADAM
05/21/19
NO CHANGE
Target $76
ADAM
Buy
Qorvo price target lowered to $76 from $87 at Canaccord
Canaccord analyst T. Michael Walkley lowered his price target for Qorvo to $76 from $87 but maintained a Buy rating after the Commerce Department added Huawei and its affiliates to its "Entity List" prohibiting U.S.-origin technology to be supplied to Huawei without a license. Huawei accounted for 13% and 8% of Qorvo's fiscal 2019 and fiscal 18 revenue, respectively, Walkley tells investors in a research note, adding that he believes Qorvo's recent stronger-than-anticipated June quarter guidance included strong share gains in Huawei handsets combined with ongoing improving shipments to Huawei for 5G infrastructure. Despite the uncertainty from the shipment ban to 10% plus customer and potential impact to the timing for the market's 5G uptake given Huawei's leadership position in infrastructure markets, the analyst says he believes the shares have priced in the news and feels Qorvo will remain focused on developing integrated solutions to drive dollar content growth to grow faster than the slow growing smartphone market and anticipate improving growth trends as 5G ramps in fiscal 2021.

TODAY'S FREE FLY STORIES

ABBV

AbbVie

$78.41

-0.37 (-0.47%)

, AGN

Allergan

$129.65

-1.32 (-1.01%)

09:31
06/25/19
06/25
09:31
06/25/19
09:31
Hot Stocks
AbbVie says looked at Allergan deal for over a year »

Says: Highly unlikely to…

ABBV

AbbVie

$78.41

-0.37 (-0.47%)

AGN

Allergan

$129.65

-1.32 (-1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 16

    Sep

MHK

Mohawk

$146.01

0.025 (0.02%)

09:31
06/25/19
06/25
09:31
06/25/19
09:31
Recommendations
Mohawk analyst commentary  »

Mohawk challenges persist…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
06/25/19
06/25
09:30
06/25/19
09:30
General news
Treasury Action: Treasuries are holding modest gains »

Treasury Action:…

09:25
06/25/19
06/25
09:25
06/25/19
09:25
Conference/Events
HSBC to hold a conference »

Transport, Infrastructure…

09:25
06/25/19
06/25
09:25
06/25/19
09:25
General news
U.S. April FHFA home price index was up 0.4% to 274.7 »

U.S. April FHFA home…

BJRI

BJ's Restaurants

$43.61

0.81 (1.89%)

, CAKE

Cheesecake Factory

$43.39

-0.79 (-1.79%)

09:25
06/25/19
06/25
09:25
06/25/19
09:25
Conference/Events
Wedbush restaurants analyst to hold an analyst/industry conference call »

Restaurants Analyst…

BJRI

BJ's Restaurants

$43.61

0.81 (1.89%)

CAKE

Cheesecake Factory

$43.39

-0.79 (-1.79%)

CMG

Chipotle

$724.14

-3.035 (-0.42%)

DIN

Dine Brands

$95.49

0.235 (0.25%)

DRI

Darden

$122.14

0.92 (0.76%)

JACK

Jack in the Box

$82.83

-2.33 (-2.74%)

SBUX

Starbucks

$83.65

-0.16 (-0.19%)

TXRH

Texas Roadhouse

$52.25

-0.1 (-0.19%)

WEN

Wendy's

$19.15

-0.22 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 09

    Jul

  • 23

    Jul

  • 08

    Aug

  • 14

    Aug

  • 21

    Aug

  • 22

    Aug

  • 27

    Aug

  • 28

    Aug

  • 13

    Nov

09:25
06/25/19
06/25
09:25
06/25/19
09:25
Conference/Events
Senate Agriculture, Nutrition & Forestry Committee to hold a hearing »

The Committee holds a…

MOR

MorphoSys

$26.23

1.16 (4.63%)

09:25
06/25/19
06/25
09:25
06/25/19
09:25
Conference/Events
MorphoSys to host analyst & investor meeting »

Analyst & Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 07

    Aug

09:21
06/25/19
06/25
09:21
06/25/19
09:21
Conference/Events
Goldman Sachs to hold a conference »

15th Annual European…

CBMG

Cellular Biomedicine

$15.01

(0.00%)

09:21
06/25/19
06/25
09:21
06/25/19
09:21
Initiation
Cellular Biomedicine initiated  »

Cantor Fitzgerald bullish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LH

LabCorp

$169.36

-1.48 (-0.87%)

, DGX

Quest Diagnostics

$100.87

-0.43 (-0.42%)

09:21
06/25/19
06/25
09:21
06/25/19
09:21
Recommendations
LabCorp, Quest Diagnostics analyst commentary  »

Deutsche says…

LH

LabCorp

$169.36

-1.48 (-0.87%)

DGX

Quest Diagnostics

$100.87

-0.43 (-0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

09:20
06/25/19
06/25
09:20
06/25/19
09:20
General news
U.S. Case Shiller home price index rose 0.8% in April to 215.68 for the 20-City index »

U.S. Case Shiller home…

PRPO

Precipio

$2.93

-0.11 (-3.62%)

09:19
06/25/19
06/25
09:19
06/25/19
09:19
Hot Stocks
Precipio initiates second development project with H3 Biomedicine for gene panel »

Precipio announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
06/25/19
06/25
09:18
06/25/19
09:18
Options
Overnight activity included 195 trades in SPX and 9 trades in VIX »

195 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$45.69

-3.67 (-7.44%)

, CELG

Celgene

$93.48

-5.44 (-5.50%)

09:12
06/25/19
06/25
09:12
06/25/19
09:12
Recommendations
Bristol-Myers, Celgene analyst commentary  »

Bristol-Myers sentiment…

BMY

Bristol-Myers

$45.69

-3.67 (-7.44%)

CELG

Celgene

$93.48

-5.44 (-5.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 25

    Jul

  • 03

    Sep

  • 16

    Sep

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

MSFT

Microsoft

$137.80

0.86 (0.63%)

09:11
06/25/19
06/25
09:11
06/25/19
09:11
Conference/Events
Jefferies software analyst to hold an analyst/industry conference call »

Software Analyst DiFucci…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 10

    Jul

  • 06

    Aug

PYDS

Payment Data Systems

$3.39

(0.00%)

09:10
06/25/19
06/25
09:10
06/25/19
09:10
Hot Stocks
Payment Data Systems to change name to Usio »

Payment Data Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

09:10
06/25/19
06/25
09:10
06/25/19
09:10
General news
FX Action: USD-CAD »

FX Action: USD-CAD headed…

TELNY

Telenor

$0.00

(0.00%)

09:08
06/25/19
06/25
09:08
06/25/19
09:08
Downgrade
Telenor rating change  »

Telenor downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

AGN

Allergan

$129.65

-1.32 (-1.01%)

, ABBV

AbbVie

$78.41

-0.37 (-0.47%)

09:07
06/25/19
06/25
09:07
06/25/19
09:07
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Allergan (AGN),…

AGN

Allergan

$129.65

-1.32 (-1.01%)

ABBV

AbbVie

$78.41

-0.37 (-0.47%)

PYX

Pyxus

$13.42

-1.1 (-7.58%)

ARQL

ArQule

$10.00

-0.48 (-4.58%)

LEN

Lennar

$51.41

0.09 (0.18%)

BHF

Brighthouse Financial

$38.10

-0.01 (-0.03%)

PVTL

Pivotal Software

$11.35

-0.15 (-1.30%)

SBH

Sally Beauty

$12.30

-2.49 (-16.84%)

ALDX

Aldeyra

$7.08

-0.29 (-3.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 27

    Jun

  • 28

    Jun

  • 11

    Jul

  • 16

    Sep

  • 25

    Jun

09:06
06/25/19
06/25
09:06
06/25/19
09:06
General news
FHFA House Price Index M/M change data reported »

April FHFA House Price…

AETI

American Electric Tech.

$0.69

-0.0099 (-1.41%)

09:05
06/25/19
06/25
09:05
06/25/19
09:05
Hot Stocks
American Electric Tech. receives $725,000 distribution from Bomay joint venture »

American Electric Tech.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

09:05
06/25/19
06/25
09:05
06/25/19
09:05
General news
NY Fed's Williams didn't discuss monetary policy or the economy »

NY Fed's Williams…

09:04
06/25/19
06/25
09:04
06/25/19
09:04
General news
S&P/Corelogic Case-Shiller Home Price Index data reported. »

April S&P/Corelogic…

ZTS

Zoetis

$113.46

0.6 (0.53%)

09:03
06/25/19
06/25
09:03
06/25/19
09:03
Recommendations
Zoetis analyst commentary  »

Zoetis price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.